rs6743496

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014905.5(GLS):​c.1038+2268A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.466 in 151,824 control chromosomes in the GnomAD database, including 19,284 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 19284 hom., cov: 30)

Consequence

GLS
NM_014905.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.577

Publications

3 publications found
Variant links:
Genes affected
GLS (HGNC:4331): (glutaminase) This gene encodes the K-type mitochondrial glutaminase. The encoded protein is an phosphate-activated amidohydrolase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. This protein is primarily expressed in the brain and kidney plays an essential role in generating energy for metabolism, synthesizing the brain neurotransmitter glutamate and maintaining acid-base balance in the kidney. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
STAT1 (HGNC:11362): (signal transducer and activator of transcription 1) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]
STAT1 Gene-Disease associations (from GenCC):
  • autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, Orphanet
  • immunodeficiency 31B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.613 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLSNM_014905.5 linkc.1038+2268A>G intron_variant Intron 7 of 17 ENST00000320717.8 NP_055720.3 O94925-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLSENST00000320717.8 linkc.1038+2268A>G intron_variant Intron 7 of 17 1 NM_014905.5 ENSP00000317379.3 O94925-1

Frequencies

GnomAD3 genomes
AF:
0.466
AC:
70717
AN:
151706
Hom.:
19275
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.624
Gnomad AMR
AF:
0.416
Gnomad ASJ
AF:
0.526
Gnomad EAS
AF:
0.157
Gnomad SAS
AF:
0.497
Gnomad FIN
AF:
0.669
Gnomad MID
AF:
0.424
Gnomad NFE
AF:
0.618
Gnomad OTH
AF:
0.476
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.466
AC:
70759
AN:
151824
Hom.:
19284
Cov.:
30
AF XY:
0.468
AC XY:
34707
AN XY:
74214
show subpopulations
African (AFR)
AF:
0.210
AC:
8705
AN:
41416
American (AMR)
AF:
0.416
AC:
6335
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.526
AC:
1823
AN:
3466
East Asian (EAS)
AF:
0.156
AC:
808
AN:
5178
South Asian (SAS)
AF:
0.498
AC:
2392
AN:
4808
European-Finnish (FIN)
AF:
0.669
AC:
7041
AN:
10526
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.618
AC:
41964
AN:
67884
Other (OTH)
AF:
0.474
AC:
998
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1616
3232
4849
6465
8081
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
626
1252
1878
2504
3130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.516
Hom.:
3199
Bravo
AF:
0.436
Asia WGS
AF:
0.358
AC:
1242
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.6
DANN
Benign
0.27
PhyloP100
-0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6743496; hg19: chr2-191777315; API